Evidence map›Paper›PMID 39380572›Full record

ArticleFood chemistry: X2024

Enzymatic hydrolysis pretreatment combined with glycosylation for soybean protein isolate applying in dual-protein yogurt.

Mengya Sun, Zhenhai Yu, Shuo Zhang, Caihua Liu, Zengwang Guo, Jing Xu, Guofang Zhang, Zhongjiang Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food chemistry: X, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mengya SunCollege of Food Science, Northeast Agricultural University, Harbin, Heilongjiang 150030, China.
Zhenhai YuHeilongjiang Province Green Food Science Institute, Harbin, Heilongjiang 150030, China.
Shuo ZhangCollege of Food Science, Northeast Agricultural University, Harbin, Heilongjiang 150030, China.
Caihua LiuCollege of Food Science, Northeast Agricultural University, Harbin, Heilongjiang 150030, China.
Zengwang GuoCollege of Food Science, Northeast Agricultural University, Harbin, Heilongjiang 150030, China.
Jing XuCollege of Food Science, Northeast Agricultural University, Harbin, Heilongjiang 150030, China.
Guofang ZhangCollege of Food Science, Northeast Agricultural University, Harbin, Heilongjiang 150030, China.
Zhongjiang WangCollege of Food Science, Northeast Agricultural University, Harbin, Heilongjiang 150030, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This research investigated the viability of replacing milk protein with glycosylated soybean protein isolate (SPI) treated with different enzymatic hydrolysis times (0, 10, 20, 30, 40, and 50 min) in yogurt. The results showed that enzymatic hydrolysis pretreatment combined with glycosylation for SPI exhibited elevated grafting and solubility. Additionally, the high solubility of SPI (94.77 %) at 40 min facilitates the preparation of dual-protein yogurt (DPY). Compared to ESPI0-G, DPY that incorporates ESPI40-G through partial substitution of milk protein is capable of forming a denser and more stable gel matrix. Especially, the syneresis of DPY40 was reduced by 7.61 % compared to DPY0, which more closely approximates the texture properties of traditional yogurt. Meanwhile, glycosylated SPI treated with enzymatic hydrolysis can effectively degrade the beany flavor and slightly bitter taste in DPY. This study could provide a solid theoretical basis for the broader application and industrialization of plant-based yogurt.

Indexed as

Dual-proteinEnzymatic hydrolysisGlycosylationSoybean protein isolateYogurt

Identifiers

PMID39380572
PMCPMC11459005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.